SPX4,297.14+16.99 0.40%
DIA339.37+1.54 0.46%
IXIC13,128.05+80.87 0.62%

--Morgan Stanley Lowers Avient's Price Target to $50 From $63, Maintains Equalweight Rating

--Morgan Stanley Lowers Avient's Price Target to $50 From $63, Maintains Equalweight Rating

MT Newswires · 07/28/2022 07:21

Please log in to view news